Xinrong Tao Selected Research

Coal (Coals)

1/2022	Vitamin D3 suppresses astrocyte activation and ameliorates coal dust-induced mood disorders in mice.
1/2022	Inflammation and fibrosis in the coal dust-exposed lung described by confocal Raman spectroscopy.
1/2022	Coal dust exposure triggers heterogeneity of transcriptional profiles in mouse pneumoconiosis and Vitamin D remedies.
1/2021	RNA-seq-Based Screening in Coal Dust-Treated Cells Identified PHLDB2 as a Novel Lung Cancer-Related Molecular Marker.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinrong Tao Research Topics

Disease

10	Infections 12/2016 - 01/2013
4	Inflammation (Inflammations) 02/2022 - 01/2016
4	Fibrosis (Cirrhosis) 02/2022 - 12/2021
4	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2021 - 01/2016
3	Silicosis 02/2022 - 12/2021
3	Severe Acute Respiratory Syndrome 11/2020 - 01/2014
2	Pneumoconiosis 01/2022 - 01/2022
2	Opioid-Related Disorders (Opiate Addiction) 02/2016 - 01/2016
2	Morphine Dependence 02/2016 - 01/2016
1	Mood Disorders (Mood Disorder) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Anthracosis 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022
1	Necrosis 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Anxiety Disorders (Anxiety Disorder) 01/2021
1	Tuberculosis (Tuberculoses) 01/2019
1	Liver Neoplasms (Liver Cancer) 06/2017
1	Coronavirus Infections 03/2016
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 03/2016
1	Edema (Dropsy) 01/2016
1	Chronic Pain 01/2016
1	Acute Pain 01/2016
1	Osteosarcoma (Osteogenic Sarcoma) 01/2016
1	Pain (Aches) 01/2016
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2014
1	Virus Diseases (Viral Diseases) 04/2014

Drug/Important Bio-Agent (IBA)

11	VaccinesIBA 11/2020 - 01/2013
6	Proteins (Proteins, Gene)FDA Link 11/2020 - 01/2013
4	Silicon Dioxide (Silica)FDA LinkGeneric 02/2022 - 12/2021
4	Coal (Coals)IBA 01/2022 - 01/2021
4	Neutralizing AntibodiesIBA 12/2016 - 01/2013
3	CollagenIBA 02/2022 - 01/2016
3	Pharmaceutical PreparationsIBA 02/2022 - 01/2016
3	Vitamin D FDA LinkGeneric 01/2022 - 01/2021
3	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 01/2016
3	Naloxone (Narcan)FDA LinkGeneric 01/2021 - 01/2016
3	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 12/2016 - 01/2013
3	Subunit VaccinesIBA 03/2016 - 10/2014
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2022
2	Nicotine FDA Link 01/2021 - 02/2016
2	Recombinant ProteinsIBA 11/2020 - 07/2020
2	Morphine (MS Contin)FDA LinkGeneric 02/2016 - 01/2016
1	CytokinesIBA 02/2022
1	CaspasesIBA 02/2022
1	Death Domain ReceptorsIBA 02/2022
1	Phosphotransferases (Kinase)IBA 02/2022
1	Cytochromes c (Cytochrome c)IBA 01/2022
1	Cytidine Diphosphate (CDP)IBA 01/2022
1	Beclin-1IBA 01/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022
1	Cholecalciferol (Vitamin D3)FDA Link 01/2022
1	Particulate MatterIBA 01/2022
1	Coloring Agents (Dyes)IBA 12/2021
1	SuspensionsIBA 12/2021
1	Heroin (Diamorphine)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Toll-Like Receptor 2IBA 01/2019
1	MicellesIBA 06/2017
1	Docetaxel (Taxotere)FDA Link 06/2017
1	Immunoglobulin G (IgG)IBA 03/2016
1	MF59 oil emulsionIBA 03/2016
1	5-HT2C Serotonin ReceptorIBA 02/2016
1	lorcaserinIBA 02/2016
1	Clonidine (ST 155)FDA LinkGeneric 02/2016
1	Cocaine (Cocaine HCl)IBA 02/2016
1	Adrenergic Receptors (Adrenergic Receptor)IBA 02/2016
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2016
1	ZymosanIBA 01/2016
1	Monoclonal AntibodiesIBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	erythromycin propionate-N-acetylcysteinateIBA 04/2014
1	AntibodiesIBA 01/2013

Therapy/Procedure

3	Therapeutics 06/2017 - 01/2013